Login
Home
Charts
Search
Watchlist
Products

Amanta Healthcare Ltd

AMANTA·NSE
₹189.21+2.00%Wed, 23 Sept '26 15:16
Industry:Pharmaceuticals Bulk Drugs & Formulation
Indices:

Amanta Healthcare Ltd

AMANTA
NSE
₹189.21
+2.00%
|Wed, 23 Sept '26 15:16
SOICxStockScans Reports
Industry
Pharmaceuticals Bulk Drugs & Formulation
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹735Cr
Close
Close Price
₹189.21
Industry
Industry
Pharmaceuticals Bulk Drugs & Formulation
PE
Price To Earnings
45.48
PS
Price To Sales
2.52
Revenue
Revenue
₹291Cr
Rev Gr TTM
Revenue Growth TTM
7.08%
PAT Gr TTM
PAT Growth TTM
-8.31%

Quarterly Results

Standalone
Numbers
Percentage
QuarterJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
686768726571747769
Growth YoY
Revenue Growth YoY%
-4.16.29.86.85.3
Expenses
ExpensesCr
555353535056596254
Operating Profit
Operating ProfitCr
131415191515151515
OPM
OPM%
19.720.822.226.322.820.720.619.421.1
Other Income
Other IncomeCr
00101-3121
Interest Expense
Interest ExpenseCr
966665546
Depreciation
DepreciationCr
555555555
PBT
PBTCr
-136852684
Tax
TaxCr
011211221
PAT
PATCr
024641563
Growth YoY
PAT Growth YoY%
1,075.0-46.58.2-7.2-5.7
NPM
NPM%
-0.53.46.38.35.41.76.27.24.8
EPS
EPS₹
-0.10.81.52.11.20.31.41.60.8
QuarterJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
686768726571747769
Growth YoY
Revenue Growth YoY%
-4.16.29.86.85.3
Expenses
ExpensesCr
555353535056596254
Operating Profit
Operating ProfitCr
131415191515151515
OPM
OPM%
19.720.822.226.322.820.720.619.421.1
Other Income
Other IncomeCr
00101-3121
Interest Expense
Interest ExpenseCr
966665546
Depreciation
DepreciationCr
555555555
PBT
PBTCr
-136852684
Tax
TaxCr
011211221
PAT
PATCr
024641563
Growth YoY
PAT Growth YoY%
1,075.0-46.58.2-7.2-5.7
NPM
NPM%
-0.53.46.38.35.41.76.27.24.8
EPS
EPS₹
-0.10.81.52.11.20.31.41.60.8

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
184171225259280275288291
Growth
Revenue Growth%
-7.131.614.98.2-2.04.77.1
Expenses
ExpensesCr
147133173206223215228232
Operating Profit
Operating ProfitCr
3738525357606060
OPM
OPM%
20.322.423.120.420.521.720.820.4
Other Income
Other IncomeCr
217641110
Interest Expense
Interest ExpenseCr
3840493534282120
Depreciation
DepreciationCr
1617171820181919
PBT
PBTCr
-15-186235152121
Tax
TaxCr
44752466
PAT
PATCr
-19-2255-24111515
Growth
PAT Growth%
-15.7352.4-103.8272.1189.041.7-8.3
NPM
NPM%
-10.2-12.824.4-0.81.33.85.25.0
EPS
EPS₹
-7.0-8.120.5-0.81.43.74.34.2
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
184171225259280275288291
Growth
Revenue Growth%
-7.131.614.98.2-2.04.77.1
Expenses
ExpensesCr
147133173206223215228232
Operating Profit
Operating ProfitCr
3738525357606060
OPM
OPM%
20.322.423.120.420.521.720.820.4
Other Income
Other IncomeCr
217641110
Interest Expense
Interest ExpenseCr
3840493534282120
Depreciation
DepreciationCr
1617171820181919
PBT
PBTCr
-15-186235152121
Tax
TaxCr
44752466
PAT
PATCr
-19-2255-24111515
Growth
PAT Growth%
-15.7352.4-103.8272.1189.041.7-8.3
NPM
NPM%
-10.2-12.824.4-0.81.33.85.25.0
EPS
EPS₹
-7.0-8.120.5-0.81.43.74.34.2

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
27272727272939
Reserves
ReservesCr
2-2036363968181
Current Liabilities
Current LiabilitiesCr
7312310697102115141
Non Current Liabilities
Non Current LiabilitiesCr
285262214214184170197
Total Liabilities
Total LiabilitiesCr
388392392374352382558
Current Assets
Current AssetsCr
105131136131118138239
Non Current Assets
Non Current AssetsCr
283261256243234244319
Total Assets
Total AssetsCr
388392392374352382558
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
27272727272939
Reserves
ReservesCr
2-2036363968181
Current Liabilities
Current LiabilitiesCr
7312310697102115141
Non Current Liabilities
Non Current LiabilitiesCr
285262214214184170197
Total Liabilities
Total LiabilitiesCr
388392392374352382558
Current Assets
Current AssetsCr
105131136131118138239
Non Current Assets
Non Current AssetsCr
283261256243234244319
Total Assets
Total AssetsCr
388392392374352382558

Cash Flow

Standalone
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
38316243584748
Investing Cash Flow
Investing Cash FlowCr
-11-16-5-7-10-24-94
Financing Cash Flow
Financing Cash FlowCr
-37-18-50-42-46-23126
Net Cash Flow
Net Cash FlowCr
-10-36-61-181
Free Cash Flow
Free Cash FlowCr
271952364626-32
CFO To PAT
CFO To PAT%
-200.7-140.5112.2-2,017.51,598.4444.0325.7
CFO To EBITDA
CFO To EBITDA%
101.480.0118.880.7101.078.180.9
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
38316243584748
Investing Cash Flow
Investing Cash FlowCr
-11-16-5-7-10-24-94
Financing Cash Flow
Financing Cash FlowCr
-37-18-50-42-46-23126
Net Cash Flow
Net Cash FlowCr
-10-36-61-181
Free Cash Flow
Free Cash FlowCr
271952364626-32
CFO To PAT
CFO To PAT%
-200.7-140.5112.2-2,017.51,598.4444.0325.7
CFO To EBITDA
CFO To EBITDA%
101.480.0118.880.7101.078.180.9

Ratios

Standalone
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
387735
Price To Earnings
Price To Earnings
26.045.5
Price To Sales
Price To Sales
1.32.5
Price To Book
Price To Book
1.83.3
EV To EBITDA
EV To EBITDA
9.014.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
45.752.347.337.545.149.049.649.6
OPM
OPM%
20.322.423.120.420.521.720.820.4
NPM
NPM%
-10.2-12.824.4-0.81.33.85.25.0
ROCE
ROCE%
9.011.039.913.614.114.29.09.0
ROE
ROE%
-64.9-300.688.3-3.45.510.96.86.8
ROA
ROA%
-4.9-5.614.1-0.61.02.82.72.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
387735
Price To Earnings
Price To Earnings
26.045.5
Price To Sales
Price To Sales
1.32.5
Price To Book
Price To Book
1.83.3
EV To EBITDA
EV To EBITDA
9.014.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
45.752.347.337.545.149.049.649.6
OPM
OPM%
20.322.423.120.420.521.720.820.4
NPM
NPM%
-10.2-12.824.4-0.81.33.85.25.0
ROCE
ROCE%
9.011.039.913.614.114.29.09.0
ROE
ROE%
-64.9-300.688.3-3.45.510.96.86.8
ROA
ROA%
-4.9-5.614.1-0.61.02.82.72.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Amanta Healthcare Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/bfkk648o7jb3l857whyvdhc5.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/8t2kv3hzz41ratz4j0wvgjcv.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/nhl5qc0pdak05xg9fy2t9g9k.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/ac5y849mzcmk3fdj1si9bqan.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/t36gixikoi409hck5hyf4bks.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/to88ngi2c8qyofkwmbhxkc2g.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/6r4ap7zwxgsfiwrcdgbl080x.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/a9qs7jdgtloehxxv6odu7an5.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/sa08dx9hq3n3zovt3m4ps6y7.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/4hp11hvu27gjuuiehbsvt0nh.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/xcoerqiyb00hl4fdswfgys1c.pdf

Concall Transcript Summaries — Amanta Healthcare Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3AAMANTA/transcript-notes/202606/bfkk648o7jb3l857whyvdhc5.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3AAMANTA/transcript-notes/202603/8t2kv3hzz41ratz4j0wvgjcv.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3AAMANTA/transcript-notes/202512/nhl5qc0pdak05xg9fy2t9g9k.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies